Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study

European Psychiatry

Volumn 25, Issue 1, 2010, Pages 58-65

  Romera, I ^a   Perez, V ^b   Menchon J M ^c   Delgado Cohen, H ^a   Polavieja, P ^a   Gilaberte, I ^a  

^a ELI LILLY AND COMPANY   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Major depressive disorder; Partial remission; Social and occupational functioning

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ABSENTEEISM; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL DISEASE; HAMILTON SCALE; HUMAN; JOB PERFORMANCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REMISSION; SOCIAL INTERACTION; TREATMENT DURATION;

DEPRESSIVE DISORDER, MAJOR; EMPLOYMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; REMISSION INDUCTION; SOCIAL BEHAVIOR;

EID: 73849130352     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2009.02.007     Document Type: Article

References (31)

1. Broadhead W.E., Blazer D.G., George L.K., and Tse C.K. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 264 (1990) 2524-2528
2. Corey-Lisle P.K., Nash R., Stang P., and Swindle R. Response, partial response, and nonresponse in primary care treatment of depression. Arch Intern Med 164 (2004) 1197-1204
3. De Lisio G., Maremmani I., and Perugi G. Impairment of work and leisure in depressed outpatients. J Affect Disord 10 (1986) 79-84
4. Doraiswamy P.M., Khan Z.M., Donahue R.M., and Richard N.E. Quality of life in geriatric depression: a comparison of remitters, partial responders, and nonresponders. Am J Geriatr Psychiatry 9 (2001) 423-428
5. Frank E., Prien R.F., Jarrett R.B., Keller M.B., Kupfer D.J., Lavori P.W., et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48 (1991) 851-855
6. Furukawa T.A., Takeuchi H., Hiroe T., Mashiko H., Kamei K., Kitamura T., et al. Symptomatic recovery and social functioning in major depression. Acta Psychiatr Scand 103 (2001) 257-261
7. Goldman H.H., Skodol A.E., and Lave T.R. Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 149 (1992) 1148-1156
8. Guy W. ECDEU Assessment Manual for Psychopharmacology, [Revised]. Rockville: National Institute of Mental Health, Dept of Health, Education, and Welfare publication (ADM); 1976, p. 76-338.
9. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
10. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6 (1967) 278-296
11. Hays R.D., Wells K.B., Sherbourne C.D., Rogers W., and Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry 52 (1995) 11-19
12. Hodgson T.A., and Meiners M.R. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc 60 (1982) 429-462
13. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 50 (1998) 97-108
14. Judd L.L., Paulus M.P., Wells K.B., and Rapaport M.H. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry 153 (1996) 1411-1417
15. Keller M.B. Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA 289 (2003) 3152-3160
16. Kennedy N., Foy K., Sherazi R., McDonough M., and McKeon P. Long-term social functioning after depression treated by psychiatrists: a review. Bipolar Disord 9 (2007) 25-37
17. Kocsis J.H., Schatzberg A., Rush A.J., Klein D.N., Howland R., Gniwesch L., et al. Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo. Arch Gen Psychiatry 59 (2002) 723-728
18. Miller I.W., Keitner G.I., Schatzberg A.F., Klein D.N., Thase M.E., Rush A.J., et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry 59 (1998) 608-619
19. Mintz J., Mintz L.I., Arruda M.J., and Hwang S.S. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 49 (1992) 761-768
20. Nierenberg A.A., and Wright E.C. Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry 60 (1999) 7-11
21. Opdyke K.S., Reynolds C.F., Frank E., Begley A.E., Buysse D.J., Dew M.A., et al. Effect of continuation treatment on residual symptoms in late-life depression: how well is "well"?. Depress Anxiety 4 (1996-1997) 312-319
22. Papakostas G.I., Petersen T., Denninger J.W., Tossani E., Pava J.A., Alpert J.E., et al. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine. J Clin Psychopharmacol 24 (2004) 507-511
23. Paykel E.S., Ramana R., Cooper Z., Hayhurst H., Kerr J., and Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25 (1995) 1171-1180
24. Paykel E.S., Weissman M., Prusoff B.A., and Tonks C.M. Dimensions of social adjustment in depressed women. J Nerv Ment Dis 152 (1971) 158-172
25. Romera I, Delgado-Cohen H, Perez V, Menchon JM, Polavieja P, Yruretagoyena B, Gilaberte I. Optimal cutoff point to define remission by the Hamilton Rating Scale for Depression according to normal social and occupational functioning. Presented as a poster at the International Forum of Mood and Anxiety Disorders (IFMAD) 2007. Budapest.
26. Salminen J.K., Saarijärvi S., and Raitasalo R. Depression and disability pension in Finland. Acta Psychiatr Scand 95 (1997) 242-243
27. Sobocki P., Ekman M., Agren H., Runeson B., and Jönsson B. The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression. Int J Clin Pract 60 (2006) 791-798
28. Spitzer R.L., Gibbon M., and Endicott J. Global Assessment Scale (GAS), Global Assessment of Functioning (GAF) Scale, Social and Occupational Functioning Assessment Scale (SOFAS). Mental Health Status, Functioning and Disability Measures. In: First M.B. (Ed). Handbook of psychiatric measures,. 1st ed (2000), American Psychiatric Association, Washington DC, USA 96-100
29. Wells K.B., Stewart A., Hays R.D., Burnam M.A., Rogers W., Daniels M., et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 262 (1989) 914-919
30. Zimmerman M., McGlinchey J.B., Posternak M.A., Friedman M., Boerescu D., and Attiullah N. Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: implications for how remission from depression should be defined. Psychiatry Res 141 (2006) 185-191
31. Zimmerman M., Posternak M.A., and Chelminski I. Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?. J Nerv Ment Dis 193 (2005) 170-175